AHA Releases Science Advisory on Omega-3 Use for Hypertriglyceridemia

The American Heart Association has released a Science Advisory dealing with the use of omega-3 fatty acids for the management of hypertriglyceridemia.

In 2002, the AHA recommended that patients with elevated triglycerides should maintain a daily intake of 2 to 4 grams of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, since this recommendation was released, new prescription-strength omega-3 agents have been approved by the FDA for the treatment of elevated triglycerides.

Read More...
Familial Hypertriglyceridemia With Concomitant Familial Hypobetalipoproteinemia
How to Help Your Patients Reduce High Triglycerides

Following a review of newly available data, they concluded that prescription EPA monotherapy or in combination with DHA at 4 grams per day is an effective and safe option for the reduction of triglycerides, either alone or in conjunction with other lipid-lowering agents.

—Michael Potts

Reference:

Skulas-Ray AC, Wilson PWF, Harris WS et al; the American Heart Association. Omega-3 fatty acids for the management of hypertriglyceridemia [published August 19, 2019]. Circulation. https://doi.org/10.1161/CIR.0000000000000709.